Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1)

S. Visvanathan; C. Wagner; J. Rojas; J. Kay; B. Dasgupta; E. L. Matteson; M. MacK; D. G. Baker; M. U. Rahman

doi:10.3899/jrheum.100768

Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1)

S. Visvanathan, C. Wagner, J. Rojas, J. Kay, B. Dasgupta, E. L. Matteson, M. MacK, D. G. Baker, M. U. Rahman

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	183
Number of pages	1
Journal	Journal of Rheumatology
Volume	38
Issue number	1
DOIs	https://doi.org/10.3899/jrheum.100768
State	Published - Jan 2011

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology

Access to Document

10.3899/jrheum.100768

Cite this

Visvanathan, S., Wagner, C., Rojas, J., Kay, J., Dasgupta, B., Matteson, E. L., MacK, M., Baker, D. G., & Rahman, M. U. (2011). Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1). Journal of Rheumatology, 38(1), 183. https://doi.org/10.3899/jrheum.100768

Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1). / Visvanathan, S.; Wagner, C.; Rojas, J. et al.
In: Journal of Rheumatology, Vol. 38, No. 1, 01.2011, p. 183.

Research output: Contribution to journal › Comment/debate › peer-review

Visvanathan, S, Wagner, C, Rojas, J, Kay, J, Dasgupta, B, Matteson, EL, MacK, M, Baker, DG & Rahman, MU 2011, 'Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1)', Journal of Rheumatology, vol. 38, no. 1, pp. 183. https://doi.org/10.3899/jrheum.100768

Visvanathan S, Wagner C, Rojas J, Kay J, Dasgupta B, Matteson EL et al. Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1). Journal of Rheumatology. 2011 Jan;38(1):183. doi: 10.3899/jrheum.100768

Visvanathan, S. ; Wagner, C. ; Rojas, J. et al. / Erratum : E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1). In: Journal of Rheumatology. 2011 ; Vol. 38, No. 1. pp. 183.

@article{feae66bf40b14c8989b2c46f29f5982c,

title = "Erratum: E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1)",

author = "S. Visvanathan and C. Wagner and J. Rojas and J. Kay and B. Dasgupta and Matteson, {E. L.} and M. MacK and Baker, {D. G.} and Rahman, {M. U.}",

year = "2011",

month = jan,

doi = "10.3899/jrheum.100768",

language = "English (US)",

volume = "38",

pages = "183",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy (The Journal of Rheumatology (2009) 36 (1371-1379) DOI:10.3899/jrheum. 080755C1)

AU - Visvanathan, S.

AU - Wagner, C.

AU - Rojas, J.

AU - Kay, J.

AU - Dasgupta, B.

AU - Matteson, E. L.

AU - MacK, M.

AU - Baker, D. G.

AU - Rahman, M. U.

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=78650921865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650921865&partnerID=8YFLogxK

U2 - 10.3899/jrheum.100768

DO - 10.3899/jrheum.100768

M3 - Comment/debate

AN - SCOPUS:78650921865

SN - 0315-162X

VL - 38

SP - 183

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 1

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this